AIPAC (IMP321) is currently only partnered for the Chinese market territory (Eddingpharm).
Presumably that means once trial results are in (PFS 1st half 2019) they would be in a strong position to negotiate an agreement for the worldwide marketing rights (ex China) with various parties, as a breast cancer treatment. Probably including sponsorship for a Phase 3 trial, if necessary.
.
AIPAC (IMP321) is currently only partnered for the Chinese...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
-0.010(3.03%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.0¢ | 31.0¢ | $66.60K | 210.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 125475 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 8733 | 3 |
View Market Depth
| Last trade - 10.05am 26/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
